1. Home
  2. FC vs IMRX Comparison

FC vs IMRX Comparison

Compare FC & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FC
  • IMRX
  • Stock Information
  • Founded
  • FC 1983
  • IMRX 2008
  • Country
  • FC United States
  • IMRX United States
  • Employees
  • FC N/A
  • IMRX N/A
  • Industry
  • FC Other Consumer Services
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FC Consumer Discretionary
  • IMRX Health Care
  • Exchange
  • FC Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • FC 236.1M
  • IMRX 232.9M
  • IPO Year
  • FC 1992
  • IMRX 2021
  • Fundamental
  • Price
  • FC $15.06
  • IMRX $6.46
  • Analyst Decision
  • FC Strong Buy
  • IMRX Strong Buy
  • Analyst Count
  • FC 2
  • IMRX 5
  • Target Price
  • FC $24.50
  • IMRX $17.20
  • AVG Volume (30 Days)
  • FC 98.0K
  • IMRX 1.2M
  • Earning Date
  • FC 11-05-2025
  • IMRX 11-12-2025
  • Dividend Yield
  • FC N/A
  • IMRX N/A
  • EPS Growth
  • FC N/A
  • IMRX N/A
  • EPS
  • FC 0.24
  • IMRX N/A
  • Revenue
  • FC $267,067,000.00
  • IMRX N/A
  • Revenue This Year
  • FC $4.21
  • IMRX N/A
  • Revenue Next Year
  • FC $44.35
  • IMRX N/A
  • P/E Ratio
  • FC $66.99
  • IMRX N/A
  • Revenue Growth
  • FC N/A
  • IMRX N/A
  • 52 Week Low
  • FC $15.41
  • IMRX $1.10
  • 52 Week High
  • FC $44.16
  • IMRX $10.08
  • Technical
  • Relative Strength Index (RSI)
  • FC 32.86
  • IMRX 51.38
  • Support Level
  • FC $16.29
  • IMRX $6.15
  • Resistance Level
  • FC $17.86
  • IMRX $6.80
  • Average True Range (ATR)
  • FC 0.95
  • IMRX 0.50
  • MACD
  • FC -0.20
  • IMRX 0.05
  • Stochastic Oscillator
  • FC 2.90
  • IMRX 61.32

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: